Cargando…

Intravenous immunoglobulin in the therapy of adult acute fulminant myocarditis: A retrospective study

Acute fulminant myocarditis (AFM) is a serious heart disease with limited treatment. This observational retrospective study aimed to investigate whether intravenous immunoglobulin (IVIG) was able to improve left ventricular function and reduce the episodes of arrhythmia in adult patients with AFM. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	YU, DAN-QING, WANG, YING, MA, GUI-ZHOU, XU, RONG-HE, CAI, ZHI-XIONG, NI, CHU-MIN, CHEN, PING, ZHU, ZHI-DAN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861110/ https://www.ncbi.nlm.nih.gov/pubmed/24348772 http://dx.doi.org/10.3892/etm.2013.1372

Ejemplares similares

Coronavirus Associated Fulminant Myocarditis Successfully Treated With Intravenous Immunoglobulin and Extracorporeal Membrane Oxygenation
por: Rao, Sangeetha, et al.
Publicado: (2014)

Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin
por: Hu, Hongde, et al.
Publicado: (2020)

Glucocorticoid and immunoglobulin to treat viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

FULMINANT MYOCARDITIS IN A PATIENT WITH COVID-19 AND COMPLETE MYOCARDIAL RECOVERY FOLLOWING TREATMENT WITH INTRAVENOUS IMMUNOGLOBULIN
por: Tessari, Fernanda, et al.
Publicado: (2022)

Corrigendum to: Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin
Publicado: (2020)

Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019)

Anakinra in pediatric acute fulminant myocarditis
por: Maunier, Louise, et al.
Publicado: (2022)

A Case of Influenza Associated Fulminant Myocarditis Successfully Treated with Intravenous Peramivir
por: Baik, Seung Hee, et al.
Publicado: (2015)

Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
por: Li, Yining, et al.
Publicado: (2019)

Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

COVID-Induced Fulminant Myocarditis
por: Rodriguez Guerra, Miguel A, et al.
Publicado: (2022)

Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis
por: Zhou, Ning, et al.
Publicado: (2021)

Factors Associated With In-hospital Mortality of Children With Acute Fulminant Myocarditis on Extracorporeal Membrane Oxygenation
por: Lee, En-Pei, et al.
Publicado: (2020)

Case report: VA-ECMO for fulminant myocarditis in an infant with acute COVID-19
por: Hsu, Hao-Ting, et al.
Publicado: (2023)

Acute fulminant necrotizing eosinophilic myocarditis: early diagnosis and treatment
por: Callan, Paul David, et al.
Publicado: (2017)

Acute fulminant eosinophilic myocarditis due to Giardia lamblia infection
por: Beuy, Joob, et al.
Publicado: (2019)

Fulminant myocarditis and atrial fibrillation in child with acute COVID-19
por: Kohli, Utkarsh, et al.
Publicado: (2022)

The use of extracorporeal membrane oxygenation in children with acute fulminant myocarditis
por: Heinsar, Silver, et al.
Publicado: (2020)

Fulminant Myocarditis and Acute Appendicitis after COVID-19 Vaccination
por: Kawano, Hiroaki, et al.
Publicado: (2022)

Transient Myocarditis Associated with Fulminant Colitis
por: Williamson, J. M. L., et al.
Publicado: (2011)

Fulminant Guillain-Barré Syndrome with Myocarditis
por: Mishra, Ajay, et al.
Publicado: (2014)

Fulminant myocarditis: Characteristics, treatment, and outcomes
por: Veronese, Giacomo, et al.
Publicado: (2018)

Consideration on pathogen of viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19. Response
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant myocarditis due to COVID-19
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant Eosinophilic Myocarditis and VT Storm
por: Hoppens, Kyle R., et al.
Publicado: (2021)

Tozinameran: Fulminant myocarditis: case report
Publicado: (2022)

Characteristics of Electrocardiogram Findings in Fulminant Myocarditis
por: Dai, Mei-Yan, et al.
Publicado: (2023)

Fulminant versus non fulminant acute myocarditis: evolution of functional parameters evaluated with cardiac magnetic resonance
por: Pedrotti, Patrizia, et al.
Publicado: (2016)

Use of Intravenous Immunoglobulin Therapy at Unconventional Doses in Refractory Fulminant Systemic Lupus Erythematosus
por: Binello, Nicolò, et al.
Publicado: (2018)

ECMO as an effective rescue therapeutic for fulminant myocarditis complicated with refractory cardiac arrest
por: Li, Ya-Ting, et al.
Publicado: (2017)

Prognostic factors in children with acute fulminant myocarditis receiving venoarterial extracorporeal membrane oxygenation
por: Sun, Mingwei, et al.
Publicado: (2022)

A survival case of invasive thymoma accompanied by acute fulminant myocarditis
por: Saito, Nayuta, et al.
Publicado: (2013)

Local Experience with Extracorporeal Membrane Oxygentaion in Children with Acute Fulminant Myocarditis
por: Ning, Botao, et al.
Publicado: (2013)

Rapid Resolution of Acute Fulminant Myocarditis after IVIG and Steroid Treatment
por: Barrie, Michael, et al.
Publicado: (2012)

Elasomeran: Acute fulminant lymphocytic myocarditis and cardiogenic shock: case report
Publicado: (2022)

Enterovirus fulminant myocarditis as cause of acute heart failure in a newborn
por: Annoni, Giuseppe, et al.
Publicado: (2022)

Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis
por: Wang, Jin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n5udmg1ipq69mlmv28tl5f1poi